Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2016 - 2025)
Thermo Fisher Scientific's Total Non-Current Liabilities history spans 17 years, with the latest figure at $52.7 billion for Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 20.38% year-over-year to $52.7 billion, compared with a TTM value of $52.7 billion through Dec 2025, up 20.38%, and an annual FY2025 reading of $52.7 billion, up 20.38% over the prior year.
- Total Non-Current Liabilities for Q4 2025 was $52.7 billion at Thermo Fisher Scientific, up from $47.7 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $52.7 billion in Q4 2025, with the low at $27.3 billion in Q3 2021.
- Average Total Non-Current Liabilities over 5 years is $44.2 billion, with a median of $46.9 billion recorded in 2024.
- Year-over-year, Total Non-Current Liabilities surged 71.08% in 2022 and then decreased 7.63% in 2024.
- Tracing TMO's Total Non-Current Liabilities over 5 years: stood at $49.7 billion in 2021, then dropped by 1.7% to $48.9 billion in 2022, then fell by 3.12% to $47.4 billion in 2023, then fell by 7.63% to $43.7 billion in 2024, then increased by 20.38% to $52.7 billion in 2025.
- Per Business Quant, the three most recent readings for TMO's Total Non-Current Liabilities are $52.7 billion (Q4 2025), $47.7 billion (Q3 2025), and $46.5 billion (Q2 2025).